...
首页> 外文期刊>Hemodialysis international >Statin use among Veterans with dialysis‐dependent chronic kidney disease
【24h】

Statin use among Veterans with dialysis‐dependent chronic kidney disease

机译:他汀类药物在退伍军人中使用具有透析依赖性慢性肾病

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Introduction : The benefits of statin medications in patients receiving maintenance dialysis remains controversial and clinical trials overall have shown no benefit. Potential side effects of statin medications include myalgias, myopathy, and memory loss and risk of side effects associated with statin medications increase with higher statin doses. We examined statin use and statin dose among Veterans with dialysis dependent CKD. Such information may help clinicians modulate medication use and reduce pill burden in appropriate patients. Methods : This cross‐sectional analysis ascertained medication utilization by linking records from the U.S. Department of Veteran's Affairs (VA) Managerial Cost Accounting Pharmacy National Data Extracts and Medicare Part D during calendar year 2013 for Veterans with dialysis‐dependent CKD enrolled in and/or using VA healthcare. The venue of dialysis and patient characteristics were ascertained by linking VA Medical SAS datasets, VA Fee Basis datasets (for non‐VA care paid for by VA), Medicare claims and the United States Renal Data Systems patient core files. Findings : We identified 18,494 Veterans with dialysis‐dependent CKD who were enrolled in and/or used VA healthcare, had no history of kidney transplantation, and were alive on January 1, 2014. More than half (58.1%) of Veterans with dialysis‐dependent CKD used statins and 35.7% of statin utilization was high dose. Statins were the third most commonly prescribed medication after beta blockers (64.8%) and phosphate binders (64.5%). Discussion : Statins are a commonly prescribed medication among Veterans receiving maintenance dialysis and approximately one‐third of statin utilization is high dose in this population. Future studies should examine patient preferences, comorbidities, and dialysis characteristics that impact the risks and benefits of statin use in order to identify those patients who will or will not benefit from continued statin use.
机译:摘要介绍:服用维修透析患者患者的益处仍然存在争议,临床试验总体表现出没有任何好处。他汀类药物的潜在副作用包括肌肌神经症,肌病和记忆丧失以及与他汀类药物增加的副作用的风险与高等的他汀类药物剂量增加。我们检查了他汀类药物和他汀类药物剂量,在退伍军人中,透析依赖性CKD。这些信息可以帮助临床医生调节药物使用,并降低适当患者的药丸负担。方法:这种横截面分析通过将美国退伍军事部(VA)管理成本药房国家数据提取物和Medicare Part的记录联系起来,在2013年为退伍军人依赖于和/或使用va healthcare。通过连接VA医疗SAS数据集,VA FUE BITIC DATASET(由VA的非VA Care),Medicare索赔和美国肾脏数据系统患者核心文件来确定透析和患者特征的场所。调查结果:我们确定了18,494名带透析依赖性CKD的退伍军人,他注册和/或使用VA Healthcare,没有肾移植史,并在2014年1月1日活跃。超过一半(58.1%)的退伍军人,透析 - 依赖性CKD使用他汀类药物和35.​​7%的他汀类药物利用量高剂量。 β受体阻滞剂(64.8%)和磷酸盐粘合剂(64.5%)后,他汀类药物是第三种最常见的药物。讨论:他汀类药物是一种常规规定的药物,接受维持透析,大约三分之一的他汀类药物利用率在该人群中具有高剂量。未来的研究应该检查影响他汀类药物的风险和益处的患者偏好,嗜好和透析特征,以确定那些患者或不会受益于持续的他汀类药物的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号